whole-body tumor burden

You have access
QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY
Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven M. Larson, Howard I. Scher and Hebert Alberto Vargas

Journal of Nuclear Medicine January 8, 2021, jnumed.120.256602; DOI: https://doi.org/10.2967/jnumed.120.256602

Main menu